Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here's an EXAMPLE of a helpful press release (compliments of edig)

Would TPL attempting a hostile takeover be necessarily a bad thing?

 

Why buy PTSC when they can simply make an offer for the 50% of PDS that PTSC holds?

 

 

Be well

Share
New Message
Please login to post a reply